register

Digital & Innovation

Purposeful innovation a must in enhancing customer experience, says AbbVie’s Strategy and Innovation leader

Health Industry Hub | October 12, 2022 |

Digital & Innovation: Through the recent years of unprecedented global disruption and uncertainty, leaders have taken their commitment to innovation to a whole new level. Organisations that prioritise growth and innovation during crises tend to leap ahead of competitors that retrench.

AbbVie ANZ’s commitment to innovation has been amplified by the company’s investment in a unique role that does not exist in most other pharma and medtech organisations.

Mahesh Malalage, Head of Strategy and Innovation at AbbVie ANZ joined Health Industry Hub to discuss how innovation has evolved, the business drivers that are leading organisations to invest in innovation and key gaps in innovation that need to be addressed in the current environment.

Mahesh reflected on how to build an organisational culture around innovation and the levers for success in the new hybrid working ecosystem. He shared what best practice looks like when thinking about purposeful innovation to enhance customer experience.


ESG

Edwards Lifesciences VP challenges us to 'dream bigger' for underserved communities

Edwards Lifesciences VP challenges us to ‘dream bigger’ for underserved communities

Health Industry Hub | November 11, 2024 |

Social Impact: Edwards Lifesciences ANZ held its annual Foundation Grants Day, an event that brought to life the company’s commitment […]

More


News & Trends - MedTech & Diagnostics

Government faces scrutiny for inaction in private hospital sector despite Health Check warnings

Government faces scrutiny for inaction in private hospital sector despite Health Check warnings

Health Industry Hub | November 11, 2024 |

Shadow Health Minister Senator Anne Ruston questioned the Department of Health’s commitment to addressing critical issues in the private hospital […]

More


News & Trends - MedTech & Diagnostics

Australia lags behind in funding pharmacogenomic testing: Pathologists urge action

Australia lags behind in funding pharmacogenomic testing: Pathologists urge action

Health Industry Hub | November 11, 2024 |

Diagnostics & MedTech News: The call for urgent action to improve access to pharmacogenomic testing across Australia comes as demand […]

More


News & Trends - Pharmaceuticals

Australia’s first Cholesterol Awareness Week launched to tackle nation’s 'silent disease'

Australia’s first Cholesterol Awareness Week launched to tackle nation’s ‘silent disease’

Health Industry Hub | November 11, 2024 |

Pharma News: Leading heart charities have come together to launch the nation’s first Cholesterol Awareness Week (11-17 November), aiming to […]

More


This content is copyright protected. Please subscribe to gain access.